Journals / Bilecik Şeyh Edebali Üniversitesi Fen Bilimleri Dergisi / 2020 / Cilt: 7 - Sayı: 2

A Mathematical Tumor Model with Oncolytic Virus

Onkolitik Virüs ile Matematiksel Tümör Modeli

Pages
609–620
Publication Date
2020-12-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Finally, some numerical results have been obtained for the stability analysis and numerical findings have been presented.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this study, a four-dimensional model [29] that is given for interactions between nutrient, healthy cells, tumor cells, and oncolytic virus, is extended with a five-dimensional ordinary differential equations system.
📊
Key Findings & Data:Therefore, this study demonstrates that existence of healthy cells in the host increases the chance of eradication of tumor cells, and it leads to a decrease in virus dosage.
💡
Conclusion & Impact:Finally, some numerical results have been obtained for the stability analysis and numerical findings have been presented.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Tumor model · stability analysis · oncolytic virus

Abstract

In this study, a four-dimensional model [29] that is given for interactions between nutrient, healthy cells, tumor cells, and oncolytic virus, is extended with a five-dimensional ordinary differential equations system. Infected tumor cells are included in the model since oncolytic virus infects tumor cells. In order to investigate the role of oncolytic virus in eradication of tumor burden, stability analysis has been performed in case of no tumor cells in the system. It is determined that the stability of the system in case of no tumor cells and healthy cells is related with the minimum virus dosage injected into the host. In case of no tumor cells, but healthy cells, the minimum dosage is smaller than the previous case for stability of the equilibrium point. Therefore, this study demonstrates that existence of healthy cells in the host increases the chance of eradication of tumor cells, and it leads to a decrease in virus dosage. Finally, some numerical results have been obtained for the stability analysis and numerical findings have been presented.

Özet

Besin, sağlıklı hücreler, tümör hücreleri ve onkolitik virüs arasındaki etkileşim için verilen dört boyutlu matematiksel model [29], bu çalışmada beş boyutlu adi diferansiyel denklem sistemi şeklinde genişletilmiştir. Tümör hücreleri onkolitik virüs ile etkileşime geçtiğinden, enfekte olmuş tümör hücreleri de modele dâhil edilmiştir. Onkolitik virüsün tümörü yok etmedeki rolünü incelemek için, tümörün sistemde olmadığı durumlar için kararlılık analizi yapılmıştır. Tümör ve sağlıklı hücrelerden yoksun bir sistemin kararlılığının, sisteme verilen virüs dozunun minimum değerine bağlı olduğu tespit edilmiştir. Tümörün olmadığı ve sağlıklı hücrelerin var olduğu durumda ise, sistemin kararlılığı için elde edilen minimum virüs dozunun, bir önceki dozdan daha küçük olduğu gözlemlenmiştir. Böylece, sistemde sağlıklı hücrelerin bulunmasının, tümörün yok edilme şansını artırdığı ve gerekli ilaç dozunun azaltılmasını sağladığı sonucuna varılmıştır. Son olarak, elde edilen kararlılık analizi için nümerik sonuçlar elde edilmiş ve sistemin kararlılığı için örnekler sunulmuştur.

🔖

Cite This Article

YILDIZ, T. A. (2020). A Mathematical Tumor Model with Oncolytic Virus. Bilecik Şeyh Edebali Üniversitesi Fen Bilimleri Dergisi, Cilt: 7 - Sayı: 2, 609–620. https://ajindex.com/articles/251662

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. National Cancer Institute. July, 2019. What is cancer?
  2. Schreiber, R. D., Old, L. J., & Smyth, M. J. (2011). Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion. Science, 331(6024), 1565-1570
  3. Finn, O. J. (2012). Immuno-oncology: understanding the function and dysfunction of the immune system in cancer. Annals of Oncology, 23(suppl_8), viii6-viii9
  4. Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004). The three Es of cancer immunoediting. Annual Reviews of Immunology, 22, 329-360
  5. Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394-424
  6. Miller, K. D., Siegel, R. L., Lin, C. C., Mariotto, A. B., Kramer, J. L., Rowland, J. H., Stein, K. D., Alteri, R. & Jemal, A. D.V.M. (2016). Cancer treatment and survivorship statistics, 2016. CA: A Cancer Journal for Clinicians, 66(4), 271-289
  7. Mamat, M., Subiyanto, K. A., & Kartono, A. (2013). Mathematical model of cancer treatments using immunotherapy, chemotherapy and biochemotherapy. Applied Mathematical Sciences, 7(5), 247-261
  8. Melief, C. J. (2008). Cancer immunotherapy by dendritic cells. Immunity, 9(3), 372-383
  9. Senkus-Konefka, E., & Jassem, J. (2006). Complications of breast-cancer radiotherapy. Clinical Oncology, 18(3), 229-235
  10. Brennan, M. F. (2005). Current status of surgery for gastric cancer: A review. Gastric Cancer, 8(2), 64-70
  11. Zhang, J., Yang, P. L., & Gray, N. S. (2009). Targeting cancer with small molecule kinase inhibitors. Nature Reviews Cancer, 9(1), 28
  12. Russell, S. J., Peng, K. W., & Bell, J. C. (2012). Oncolytic virotherapy. Nature Biotechnology, 30(7), 658
  13. Kuznetsov, V. A., Makalkin, I. A., Taylor, M. A., & Perelson, A. S. (1994). Nonlinear dynamics of immunogenic tumors: parameter estimation and global bifurcation analysis. Bulletin of Mathematical Biology, 56(2), 295-321
  14. Enderling, H., & Chaplain, M. A. J. (2014). Mathematical modeling of tumor growth and treatment. Current pharmaceutical design, 20(30), 4934-4940
  15. De Pillis, L. G., Radunskaya, A. E., & Wiseman, C. L. (2005). A validated mathematical model of cellmediated immune response to tumor growth. Cancer Research, 65(17), 7950-7958
  16. Webb, S. D., Sherratt, J. A., & Fish